Epidemiology of systemic sclerosis: incidence, prevalence, survival, risk factors, malignancy, and environmental triggers

J Barnes, MD Mayes - Current opinion in rheumatology, 2012 - journals.lww.com
Prevalence and incidence of SSc appears to be greater in populations of European ancestry
and lower in Asian groups. Exposure to silica dust appears to be an environmental trigger, …

Scleroderma epidemiology

MD Mayes - Rheumatic Disease Clinics, 2003 - rheumatic.theclinics.com
Epidemiology is the study of the pattern of disease occurrence to identify key determinants
of risk, causation, and prevention. The following questions are relevant about systemic …

International consensus criteria for the diagnosis of Raynaud's phenomenon

…, M Matucci-Cerinic, FA Wollheim, MD Mayes… - Journal of …, 2014 - Elsevier
Vasoconstriction accompanied by changes in skin color is a normal physiologic response to
cold. The distinction between this normal physiology and Raynaud's phenomenon (RP) has …

2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative

…, DE Furst, A Gabrielli, MD Mayes… - Arthritis & …, 2013 - Wiley Online Library
Mayes has received consulting fees, speaking fees, and/or honoraria from Actelion, Practice
Point Communications, and Medtelligence (less than $10,000 each) and receives royalties …

Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part I

…, MH Liang, HM Kremers, MD Mayes… - Arthritis & …, 2008 - Wiley Online Library
Objective. To provide a single source for the best available estimates of the US prevalence of
and number of individuals affected by arthritis overall, rheumatoid arthritis, juvenile arthritis, …

Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population

MD Mayes, JV Lacey Jr… - … : Official Journal of …, 2003 - Wiley Online Library
Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large
US population - Mayes - 2003 - Arthritis & Rheumatism - Wiley Online Library …

[HTML][HTML] Nintedanib for systemic sclerosis–associated interstitial lung disease

…, A Azuma, A Fischer, MD Mayes… - … England Journal of …, 2019 - Mass Medical Soc
Background Interstitial lung disease (ILD) is a common manifestation of systemic sclerosis
and a leading cause of systemic sclerosis–related death. Nintedanib, a tyrosine kinase …

2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative

…, O Distler, Y Allanore, DE Furst, A Gabrielli, MD Mayes… - 2013 - deepblue.lib.umich.edu
Mayes has received consulting fees, speaking fees, and/or honoraria from Actelion, Practice
Point Communications, and Medtelligence (less than $10,000 each) and receives royalties …

Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon

…, RW Martin, JJ Anderson, MD Mayes… - Arthritis & …, 2002 - Wiley Online Library
Objective To document disease activity and functional status in patients with scleroderma (systemic
sclerosis [SSc]) and Raynaud's phenomenon (RP) and to determine the sensitivity to …

[HTML][HTML] Myeloablative autologous stem-cell transplantation for severe scleroderma

…, A Pinckney, B Welch, MD Mayes… - … England Journal of …, 2018 - Mass Medical Soc
Background Despite current therapies, diffuse cutaneous systemic sclerosis (scleroderma)
often has a devastating outcome. We compared myeloablative CD34+ selected autologous …